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Abstract 
The present research is designed to examine the potential role of the placebo effect in the 
benefits of physical exercise. To this end, 64 healthy non-exercising young adults were 
randomly assigned to a positive expectancy, negative expectancy, or no-information control 
group. Participants were asked to track their level of daily activity by wearing a pedometer 
for two days and were informed about the physical and psychological benefits of regular 
exercise. Participants in the positive expectancy group received feedback that their daily 
level of activity indicated that they were living an active lifestyle according to American 
College of Sports Medicine (ACSM) recommendations, and thus should be receiving the 
corresponding physical and psychological benefits associated with regular exercise. 
Participants in the negative expectancy group were informed that they were not meeting 
minimum ACSM standards of daily activity, and thus were not receiving the benefits of an 
active lifestyle. The no information control group did not receive feedback regarding their 
level of daily activity. Participants completed a battery of psychological and physiological 
measures during the initial meeting, directly following expectancy manipulations, and at a 
one-week follow-up appointment. Based on the expectancy model of placebo effects, it was 
hypothesized that participants receiving the positive expectancy manipulation would show 
improved scores on psychological and physiological measures, whereas the negative 
expectancy and control groups would show little or no change in outcomes.  Results revealed 
that participants in the positive expectancy group reported significant increases in perceived 
level of daily activity and benefits of current level of physical activity on psychological 
wellbeing. However, these changes in participant perceptions did not correspond with 
significant effects on any of the psychological or physiological outcome measures.   
                               Placebo Expectations     3 
 
Placebo Expectancies as a Mechanism in the Psychological and  
Physiological Benefits of Physical Activity 
The word placebo is derived from the Latin word “placare” meaning to please 
(Rajagopal, 2006). A placebo is a substance or procedure that, despite containing no inherent 
power to generate a specific effect, produces a genuine psychological or physiological 
response (Stewart-Williams, 2004). Thus, placebo effects are conceptualized as effects that, 
though attributable to the administration of a substance or procedure, are not directly caused 
by the inherent powers of a substance or procedure (Stewart-Williams & Podd, 2004). The 
effects of placebos are so well-documented that it has become standard practice in drug trials 
and many therapy outcome studies to compare active treatments with placebos. Although the 
mechanisms of the therapeutic effects of placebos remain controversial, two prominent 
theories have emerged to explain the placebo effect: the Expectancy Model and Classical 
Conditioning Model (Geers, Weiland, Kosbab, Landry, & Helfer, 2005).  
Expectancy Model 
An expectation can be defined as a belief about the likelihood that a future event will 
occur (Olson, Roese, & Zanna, 1996). The expectancy model of placebo effects holds that a 
placebo functions by eliciting an expectation for a specific effect, and that the expectation in 
turn generates the effect. Thus, if an individual believes that a treatment will be beneficial, 
the expectation of physical or psychological improvement leads to the beneficial effect of the 
treatment. Expectancies can be acquired through a variety of mechanisms, such as direct 
personal experience, observational learning, or verbal suggestion. According to expectancy 
theory (Kirsch, 1985, 1990, 1997), some of the effects of expectancies are unmediated, and 
thus the expectation of an effect leads directly to the experience of that effect. In contrast, 
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other expectancy effects may be mediated by other variables, such as motivation (Geers et 
al., 2005). For example, research appears to indicate that the strength of the analgesic effect 
of placebos in studies of pain regulation is related to a combination of desire for reduced pain 
and expectancy of pain reduction (Vase, Robinson, Verne, & Price, 2003). Thus, expectancy 
theorists do not necessarily purport that expectancies alone can account for all placebo 
effects. Rather, expectancies are considered the most important variable involved in the 
placebo effect (Kirsch, 1999).  
A considerable body of research has accumulated supporting the expectancy model of 
placebo effects. For example, expectancies have been shown to predict placebo analgesia 
(e.g., Montgomery & Kirsch, 1997; Price et al., 1999) and placebo-induced physiological 
arousal (Kirsch & Sapirstein, 1998). In one study, Price et al. (1999) manipulated the 
perceived efficacy of three placebo analgesic creams, thus reducing anticipated levels of pain 
during the application of a pain stimulus. Results indicated that expected levels of pain 
accounted for 25% to 36% of pain ratings following the stimulus. In another study, Kirsch 
and Sapirstein (1998) found that participants who ingested placebo caffeine demonstrated 
increased heart rates and motor performance, as well as several other effects that were 
consistent with participants’ expectations but inconsistent with the pharmacological effects of 
caffeine. Thus, expectations regarding the effects of a stimulus appear to have the power to 
produce real, measureable changes in the experience of the stimulus.  
Classical Conditioning Model 
 The second major approach to explaining the placebo effect is derived from classical 
conditioning theory. According to the classical conditioning framework, an active treatment 
or procedure serves as an unconditioned stimulus. The method or techniques used to 
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administer the treatment become conditioned stimuli, and the placebo effect is the 
conditioned response to the methods or techniques. Much of the support for classical 
conditioning as a mechanism of the placebo effect stems from nonhuman animal research 
(Stewart-Williams & Podd, 2004). For example, Ader and Cohen (1982) demonstrated 
conditioned immunological responses to placebo stimuli in laboratory mice by pairing a 
solution of sodium saccharin (a conditioned stimulus) with cyclophosphamide, an 
immunosuppressive drug as (unconditioned stimulus). Subsequently, the mice showed 
responses to sodium saccharin alone when cyclophosphamide was removed. More recently, 
Giang et al. (1996) found similar results of conditioned placebo responses in humans. 
Multiple sclerosis patients displayed decreased counts of peripheral leukocytes with the 
intravenous administration of anise-flavored syrup alone, following four treatments with 
cyclophosphamide paired with the syrup. 
Competing or Complementary Models? 
 Expectancy and classical conditioning models have traditionally been regarded as 
competing explanations of the mechanisms of the placebo effect, and considerable research 
has been conducted in an effort to differentiate the two approaches (e.g., Kirsch, 1991; 
Montgomery & Kirsch, 1997; Voudouris, Peck, & Coleman, 1990). For example, proponents 
of the expectancy model cite research indicating that although placebo responses generally 
mimic the effects of the active drug, the placebo response will follow the expected response 
rather than the drug’s pharmacological effect when expectancies are contrary to the effects of 
the active drug, (e.g., Kirsch, 1985). In contrast, some research indicates that conditioned 
responses to placebos can occur without the involvement of conscious expectancies. For 
example, Benedetti and colleagues (1998) found that medical patients who had been 
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conditioned with an opioid drug, a side effect of which is respiratory depression, 
subsequently demonstrated respiratory depression in response to a placebo despite never 
being told that this was a potential side effect and not being aware that it had occurred. Thus, 
evidence exists to support both the classical conditioning and expectancy approaches to 
explaining the placebo effect in at least some circumstances where the other approach cannot.  
Rather than focusing on uncovering evidence for the superiority of one model over 
the other, some researchers have recently begun to work on integrating the expectancy and 
classical conditioning models. For example, Stewart-Williams and Podd (2004) suggest that 
expectancy and classical conditioning theories should not be viewed as competing 
explanations of placebo responses. Rather, conditioning and verbal information both have the 
ability to shape placebo effects. In some instances, conditioning procedures affect conscious 
expectancies, which in turn mediate some placebo effects. In other cases, conditioning 
procedures lead to placebo effects that are not affected by conscious expectations. Stewart-
Williams and Podd (2004) propose that when considering classical conditioning and 
expectancy mechanisms of placebo responses, it is necessary to consider the type of learning 
and mediation involved in shaping the placebo effect. Placebo responses may follow 
conditioned responses in certain instances or consciously mediated expectancies in other 
cases depending on whether the dominant form of learning is consciously mediated. 
Research on the Placebo Effect 
Although the mechanisms through which placebos exert their effects remain 
controversial, the existence of the placebo effect is well-documented. In fact, the placebo 
effect is so well-established that it has become standard practice in modern treatment 
outcome research to compare the efficacy of new treatments with placebos, and estimates 
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indicate that more placebos have been dispensed than any other experimental treatment 
(Kirsch & Sapirstein, 1998). Research has demonstrated that the placebo effect plays a role in 
the efficacy of a variety of procedures and treatment methods. One construct that has 
received substantial attention with regard to the role of placebo effects is pain and analgesic 
treatments (Wager, 2005; Wager et. al. 2004; Montgomery & Kirsch, 1996; Benedetti et al. 
2006). Most studies examining placebo analgesic responses have used verbal suggestions of 
analgesia to alter expectations of pain (Colloca & Benedetti, 2005). For example, 
Montgomery and Kirsch (1996) applied a topical placebo anesthetic mixture to one of the 
participants’ index fingers and induced identical pain stimuli to participants’ right and left 
index fingers. Significant reductions in pain were reported in the finger that received the 
placebo treatment. Recent research using brain imaging technology has indicated that 
placebos can reliably alter pain-related neurological functioning. Wager et al. (2004) used 
functional magnetic resonance imaging (fMRI) to show that brain regions involved in pain 
sensitivity have decreased neural activity as a result of placebo manipulation. Specifically, 
Wager et al. (2004) found decreased activity in the thalamus, insula, and anterior cingulate 
cortex, brain regions associated with pain-sensitivity, related to placebo analgesia. 
Additionally, increased activity in the prefrontal cortex was evidenced in anticipation of pain. 
These results suggest that the experience of pain can be reliably altered by the administration 
of placebo treatments.  
A number of other conditions have also been shown to be amenable to placebos. For 
example, Khan et al. (2005) studied effects of placebos compared to active psychotropic 
drugs in several diagnostic groups. Results indicated statistically significant differences in the 
effects of placebos between groups, with the strongest response among individuals suffering 
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from generalized anxiety disorder (GAD), panic disorder, and depression. In addition, a 
recent meta-analysis of over 2,000 antidepressant medication trials has revealed that only 
25% of the drug effects could be attributed to active ingredients in the drugs, whereas the 
placebo effect accounted for approximately half of the noted effects (Kirsch & Sapirstein, 
1998). Thus, the potential impact of placebo responses appears to be substantial, and placebo 
effects have been shown to play a role in a variety of treatment methods. 
 Exercise 
The physical and psychological benefits of regular physical exercise have been well-
documented. Regular physical activity has been identified as a significant factor in the 
prevention and rehabilitation of numerous physical disorders, including heart disease, 
hypertension, and diabetes (Berlin & Colditz, 1990; Morris, Clayton, Everitt,, Semmence, & 
Burgess. 1990; Gordon, Scott, Wilkinson, Duncan, & Blair, 1990; Schneider & Ruderman, 
1990). Furthermore, physical exercise has been shown to be associated with a variety of 
psychological benefits, including improvements in mood, anxiety, depression, and self-
esteem (e.g., Byrne & Byrne, 1993; Dilorenzo et al., 2000; O’Connor, Raglin, & Martinsen, 
2000). Although the benefits of exercise are far reaching and well-documented, the 
mechanisms through which exercise generates these benefits are not well understood. A 
variety of physiological and psychological hypotheses have been proposed to explain the 
effects of exercise on physical and psychological functioning (e.g., Folkins & Sime, 1981), 
though research does not appear to provide substantial support for any one theory. Recently, 
some researchers have begun to suggest that the placebo effect may be able to explain the 
ostensible psychological and physiological benefits of physical exercise (Desharnais, Jobin, 
Cote, Levesque, & Godin, 1993; Crum & Langer, 2007). 
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Exercise and the Placebo Effect 
In the first empirical study to investigate the potential link between the placebo effect 
and exercise outcomes, Desharnais et al. (1993) randomly assigned 48 healthy young adults 
involved in a 10-week supervised exercise program to receive information that the exercise 
program was designed to improve their psychological well-being or no psychological 
information. Experimental participants were also reminded of the psychological benefits of 
exercise throughout the duration of the program and asked to be aware of both biological and 
psychological improvements. Participants assigned to the control group were told of the 
biological benefits of participation in the program, though no mention of potential 
improvements in psychological well-being was made. At post assessment, results indicated 
that the experimental group perceived their exercise program to be more psychologically 
beneficial than the control group (Cohen d = 0.60). However, the groups did not differ in 
their perceptions of physical benefit of the program or actual improvements in aerobic fitness 
(VO2max). With regard to the effects of the information on psychological functioning, results 
revealed that the experimental group experienced significantly greater increases in self-
esteem scores than the control group. Thus, these findings provide initial empirical support 
for the notion that placebo expectations may play a role in at least some of the psychological 
benefits associated with exercise participation.  
In a recent study, Crum and Langer (2007) investigated the role of the placebo effect 
in the physiological benefits of exercise in 84 female room attendants across seven hotels. 
The room attendants were assigned to experimental or control conditions by hotel and told 
that the study was designed to acquire information concerning the health of hotel attendants 
in order to find ways to improve it. All participants were informed of the benefits of exercise; 
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however, the informed group received additional information regarding the ways in which 
their occupational activities were beneficial to their health, constituted regular exercise, and 
actually exceeded the necessary activity level to be physically healthy based on the Surgeon 
General’s recommendations. For example, they were told that vacuuming for 15 minutes 
resulted in approximately 50 burned calories. In contrast, the control group was not given any 
information about their current exercise involvement. Results indicated that, though there 
were no changes in actual levels of activity among either condition during the four week 
study, the informed group perceived a significant increase in the amount of exercise they 
were getting (η
2
 = .09) and the degree to which their work involved exercise. Results further 
indicated that informed participants exhibited significant decreases in weight (η
2
 = .13), 
percentage body-fat (η
2
 = .13); waist-to-hip ratio (η
2
 = .10), and systolic blood pressure (η
2
 = 
.10). In contrast, the control group did not evidence statistically significant improvements on 
any of the outcome measures. Thus, the mere perception of increased exercise appears to 
produce positive physiological changes independent of changes in actual exercise. 
 Although research by Desharnais et al. (1993) and Crum and Langer (2007) represent 
important first steps in understanding the role of placebo expectations in the physiological 
and psychological benefits of exercise, these studies are limited in several ways. First, the 
Crum and Langer (2007) study lacked individualized random assignment, thus limiting 
internal validity and the ability of researchers to rule out possible environmental variables 
that may have contributed to the physiological improvements in the experimental group. In 
addition, the Desharnais et al. (1993) and Crum and Langer (2007) studies did not implement 
a double blind design, thus leaving open the possibility that experimenter biases may have 
influenced study outcomes. This design issue is particularly notable in the Desharnais et al. 
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study, which used the same two group exercise leaders (who were knowledgeable of group 
assignment) to run both the experimental and control groups. Furthermore, although 
Desharnais et al. (1993) claimed that their findings indicate that enhanced expectancies 
regarding the psychological benefits of exercise resulted in significant improvement in 
psychological functioning, self-esteem was the only measure of psychological outcomes 
included in the study. Thus, whether the benefits of placebo expectancies are specific to the 
construct of self-esteem or representative of a broader effect on psychological functioning is 
unknown. In addition, Desharnais and colleagues required participants to take part in a 90-
minute supervised group exercise program three times per week for 10 consecutive weeks, 
thus potentially limiting the external validity of their research.  
The Present Study 
 The current study aimed to build on previous research and improve our understanding 
of the role of the placebo effect in the psychological and physiological benefits of exercise. 
Specifically, a double-blind experimental design was used to minimize the potential 
influence of experimenter biases on study outcomes. In addition, participants were randomly 
assigned to experimental conditions to minimize the potential influence of error variability on 
study outcomes. The present study also assessed the potential effects of exercise-related 
placebo expectancies in a variety of psychological outcomes that have been shown in 
previous research to be affected by exercise participation, including measures of depression, 
anxiety, anxiety sensitivity, stress, and positive and negative affect. The current study also 
represents the first investigation to assess both physiological and psychological outcomes in 
the same study of placebo effects in exercise. Finally, this study is the first to include a 
negative expectancy group, in addition to positive expectancy and no expectancy groups, 
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thus helping to clarify whether negative beliefs about the effects of exercise affect physical 
and psychological outcomes.  
If placebo expectations are demonstrated to play a role in the perceived physiological 
and psychological benefits of exercise, such findings would have important implications for 
mental health clinicians, physicians, personal trainers, and other health care professionals. 
Specifically, health care professionals may be able to increase the physical and psychological 
well-being of their clients by emphasizing the positive outcome expectations associated with 
physical exercise. Furthermore, if the placebo effect is shown to play a role in the 
improvement of specific areas of psychological functioning (e.g., anxiety), future research 
will be needed to determine whether the inclusion of exercise and positive expectancy 
manipulations in treatment for particular psychological disorders would provide additional 
benefits.  
Based on the findings of previous research, it was hypothesized that: 
(1) Participants’ assigned to the positive expectancy manipulation group would 
demonstrate a significant increase in perceived exercise participation and physical 
fitness, and corresponding physiological and psychological outcomes, from 
baseline to post and follow-up.  
(2) Participants assigned to the negative expectancy manipulation or no-information 
control group would not demonstrate significant changes in perceived exercise 
participation and physical fitness, and corresponding physiological and 
psychological outcomes, from baseline to post and follow-up.  
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Method 
Participants 
 To be included in the study, participants had to be: not experiencing any health 
conditions that would preclude exercise, not currently taking psychiatric medications, and not 
involved in a regular exercise regimen. Regular exercise participation was defined as more 
than one exercise session per week. An a priori power analysis revealed that a sample size of 
63 (at least 21 per group) would be required to detect a medium effect size (d = .6) with 60% 
power (alpha = .05, one-tailed). To obtain 63 participants who completed the study, 639 
prospective participants were screened (see Appendix A and Appendix B for screening 
instruments), of which 112 qualified for the study and agreed to participate. Upon completion 
of the step monitoring process, 66 participants qualified to continue in the study (5,000 ≤ 
steps ≥ 10,000), 64 of which completed. Thus, the final sample included 64 male (n = 25) 
and female (n = 39) undergraduate students who received course credit in exchange for their 
participation. Participants ranged in age from 18 to 46 (M = 19.53, SD = 4.67), and 
racial/ethnic distribution included: 81% Caucasian, 9% African American, 3% Asian, 3% 
Hispanic, and 2% American Indian. The consent process was reviewed and approved by the 
Institutional Review Board at Appalachian State University on September 15, 2008 (see 
Appendix C).   
Instruments 
The Depression Anxiety Stress Scales (DASS) is a self-report measure composed of 
42 items designed to measure levels of depression, anxiety, and stress over the span of the 
previous week (Lovibond & Lovibond, 1995). The measure contains 14 items for each of the 
three scales. Items are scored on a four-point Likert-type scale ranging from 0 to 3, with 0, 
Did not apply to me at all, to 3, Applied to me very much, or most of the time. Administration 
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of the DASS takes approximately 5-10 minutes, and results in a total negative affect score 
and depression, anxiety, and stress subscale scores (Lovibond & Lovibond, 1995). Internal 
consistency for the DASS has been demonstrated in student populations (α range from .81-
.91; Lovibond & Lovibond, 1995) and clinical samples (α range from .88 to .96; Brown, 
Chorpita, Korotitsch, & Barlow, 1997). Construct validity of the three scales has been 
demonstrated by findings of significant correlations between the Anxiety scale and other 
measures of anxiety (rs = .81 to .84) and Depression scale and measures of depression (rs = 
.74 to .79; Brown et al., 1997). Two week temporal stability in a clinical sample ranged from 
.71 to .81 (Brown et al., 1997). 
 The Rosenberg Self Esteem Scale (RSES) is designed to measure global self esteem 
(Rosenberg, 1989). The RSES is composed of 10 self-report items that are rated on a four 
point Likert scale, ranging from 0, Strongly Agree, to 3, Strongly Disagree. The RSES has 
demonstrated good internal consistency (α = .77-.88) across numerous sample groups (e.g., 
Fleming & Courtney, 1984), and good test-retest reliability with correlations between .82 and 
.85 for one-week and two-week intervals respectively (Blascovich & Tomaka, 1993; 
Rosenberg, 1986). 
The Four-Dimensional Mood Scale (4DMS) is a 20-item self-report measure 
designed to assess pleasant activation (PA, 4 items), unpleasant deactivation (UD, 5 items), 
unpleasant activation (UA, 6 items), and pleasant deactivation (PD, 5 items). Respondents 
are asked to rate how they feel about a set of adjectives “at this moment” on a five point 
Likert-type scale ranging from 1, Slightly or not at all, to 5, Extremely. The 4DMS produces 
separate scores for PA, UD, UA, and PD, obtained by summing items within each scale and 
dividing by the number of items on the scales. The 4DMS has demonstrated good internal 
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consistency, with alphas of .87 for the PA scale, .93 for the UD scale, .91 for the UA scale, 
and .88 for the PD scale (Huelsman, Nemanick, & Munz, 1998). The 4DMS subscales can be 
combined to form two bipolar scales, PA-UD and UA-PD, consistent with the familiar two-
factor model of affect. The PA-UD and UA-PD scales of the 4DMS demonstrated good 
internal consistency, with alphas of .83 for the PA-UD scale and .85 for the UA-PD scale 
(Huelsman, Furr, & Nemanick, 2003). 
The Anxiety Sensitivity Index -3 (ASI-3) is an 18-item self-report measure designed to 
assess anxiety sensitivity along the 3 factors of: Physical, Cognitive, and Social Concerns. 
Six items comprise each scale and range from 0, Very Little, to 4, Very Much (Taylor et al. 
2007). The ASI-3 was developed to address the unstable factor structures associated with the 
original measure, the Anxiety Sensitivity Index (ASI; Peterson & Reiss, 1992). Internal 
consistency estimates have yielded alphas ranging from .76 to .86 for Physical Concerns, .79 
to .91 for Cognitive Concerns, and .73 to .86 for Social Concerns (Taylor et al. 2007). The 
test-retest reliability of the ASI-3 remains to be studied. 
Procedure  
 Participants were asked to complete an informed consent form upon arrival at the first 
session (see Appendix D). They were also asked to sign a document agreeing not to make 
significant changes to their health-related behaviors (e.g., exercise participation, diet) for the 
duration of the study. Participants were told that the purpose of the research project was to 
study the typical level of physical activity among college students and asked to sign a 
document agreeing not to discuss their participation or the purpose of the study with anyone 
until the completion of the study. 
                               Placebo Expectations     16 
 
 Participants were asked to complete a demographic questionnaire inquiring about 
their age, gender, race/ethnicity, as well as factors pertinent to inclusion into the study.  The 
demographic questionnaire inquired about participants’ current level of exercise and use of 
psychiatric medication. 
Participants were randomly assigned to one of three conditions: positive expectancy 
manipulation, negative expectancy manipulation, or a no-information control group. All 
participants completed a battery of baseline psychological questionnaires, including measures 
of depression, anxiety, stress, anxiety sensitivity, self-esteem, and positive and negative 
affect. In addition, baseline physiological measures, including resting heart rate, blood 
pressure, and weight were taken. Participants were also asked to complete a short 
questionnaire inquiring about their perceived physical activity and perceived benefits gained 
from physical activity. These questions served as a manipulation check for the placebo 
manipulation. Subsequent to completing these psychological and physiological measures, 
participants were provided with a pedometer and instructed to wear it for two full days.  
Participants were asked to begin wearing the pedometer upon getting up in the morning and 
wear it for the entirety of the day. They were given a brief tutorial about wearing the 
correctly to ensure accurate step monitoring. They were instructed to record their total 
number of steps at the end of each day and enter their results in an online survey prior to a 
second session, which was scheduled for three to five days later. Participants that failed to 
enter their number of steps were asked to do so if they had gathered this information.  
Participants that failed to wear their pedometer on a given day or could not remember their 
number of steps were asked to restart the two day step monitoring process. To be included in 
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the second portion of the study (placebo manipulation) participants must have averaged 
between 5000 and 10,000 steps per day over the two day monitoring period. 
 The placebo manipulation was performed in the second session. Participants were 
shown a video that explained the physical and psychological benefits of regular physical 
exercise. In addition, participants received a written statement containing their average 
number of steps taken over their two days of step monitoring and one of three types of 
written feedback regarding their activity level based on group assignment. To ensure a 
double-blind research design, the written feedback forms were provided to participants in 
sealed envelopes and the research assistant administering the session was never aware of the 
participant’s condition assignment.  
Participants assigned to the positive manipulation group received feedback instructing 
them that they exceeded the recommended number of steps necessary to live a healthy 
lifestyle, placing them in the “Active” range according to standards established by the 
American College of Sports Medicine (ACSM; http://www.acsm.org). They were informed 
that their daily amount of walking, with little to no additional exercise, should provide them 
with the physiological and psychological benefits of regular exercise participation. 
Conversely, participants in the negative manipulation group received information indicating 
that their average number of steps per day was insufficient to maintain good physical health 
and that they were not leading an “active lifestyle” according to ACSM standards. 
Participants were told that they were not receiving the physiological and psychological 
benefits of regular exercise participation. Participants assigned to the no information control 
condition were informed of their average number of steps, but did not receive any feedback 
regarding the health-related implications of their activity level. Participants in each group 
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were also provided with a handout discussing the physical and psychological benefits of 
physical exercise. Participants were asked to read the handout prior to completing 
psychological and physiological measures. 
 Following collection of the pedometers and application of the various manipulations, 
participants were asked to complete the psychological and physiological measures, as well as 
the manipulation check a second time. Participants were then scheduled for a one-week 
follow-up appointment and reminded not to change their exercise habits until the completion 
of the study. At the one-week follow-up appointment, participants completed the 
psychological and physiological measures and the questionnaire inquiring about their 
perceived physical activity and perceived benefits gained from physical activity a third time. 
Upon completion of the study, participants were provided with a full debriefing of the study. 
All participants were provided with a list of campus counseling resources to comply with 
IRB recommendations. 
Results 
Study hypotheses were tested using separate 3 x 3 (group x assessment session) 
mixed-model analyses of variance (ANOVAs) for each of the dependent measures. If 
violations of the sphericity assumption were detected, significance tests were conducted 
using the Greenhouse-Geisser correction method. Significant interactions were analyzed by 
examining within-group simple effects, followed by post hoc mean comparisons. Tukey’s 
HSD procedure was used for mean comparisons. All significance tests were conducted two-
tailed. Additionally, post-hoc planned comparisons of the positive and negative manipulation 
groups were performed at post on all psychological and physiological variables.  
Demographics Characteristics 
                               Placebo Expectations     19 
 
Chi Square analyses indicated that the three treatment groups were comparable at 
baseline on gender χ
2
 (2, N = 66) = 2.14, p = .34 and race χ
2
 (12, N = 66) = 9.88, p = .63. One 
way ANOVA’s indicated that the groups did not differ in age, F(2, 63) = 0.44, p = .65 or 
average number of steps walked during the step monitoring period, F(2, 63) = 1.20, p = .31. 
Manipulation Check 
Participants were asked to rate four statements assessing the extent to which the 
manipulations affected their beliefs regarding their current level of exercise and the effect 
that their current level of exercise is having on their health (see Appendix E). Participants 
rated the statements at baseline, post, and follow-up on nine point Likert-type scales. The 
first inquiry was “please rate your current level of daily physical activity using the following 
scale,” with response options ranging from “very low” to “very high.” Results of a 3 X 3 
mixed model ANOVA indicated a significant main effect for time, F(2, 120) = 4.91, p = .01, 
η² = 0.08. Post hoc analyses indicated that the overall mean score of participants significantly 
increased from baseline (M = 4.43) to follow-up (M = 4.81), though scores at post (M = 4.63) 
were not significantly different from baseline or follow-up. The main effect of group was not 
significant, F(2, 60) = 0.06, p = .94, η² < 0.01 (see Table 1). 
Results indicated a significant group by time interaction, F(4, 120) = 2.49, p = .05, η² 
= 0.08. A simple effects analysis for the positive manipulation group was significant, F(2, 
40) = 6.92, p < 0.01, η² = 0.26. Post hoc analyses revealed that the positive manipulation 
group’s scores increased significantly from baseline (M = 4.19) to post (M = 4.90), with 
scores remaining significantly higher at follow-up (M = 4.76). However, scores did not 
significantly change from post to follow-up. Simple effects analysis for the negative 
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manipulation group, F(2, 42) = 2.16, p = .13, η² = 0.09, and no information control group, 
F(2, 38) = 1.08, p = .35, η² = 0.05, were non-significant. 
On the statement, “please rate the extent to which you believe that your current level 
of physical activity benefits your psychological wellbeing,” results of a 3 X 3 mixed model 
ANOVA indicated a significant main effect for time, F(2, 120) = 7.72, p < 0.01, η² = 0.11. 
Post hoc analyses indicated that the overall mean score of participants significantly increased 
from baseline (M = 4.70) to follow-up (M = 5.37) and from post (M = 5.00) to follow-up, 
though scores at post were not significantly different from baseline. The main effect of group 
was not significant, F(2, 60) = 0.96, p = .39 (see Table 1).  
Results indicated a significant group by time interaction, F(4, 120) = 2.72, p = .03, η² 
= 0.08. A simple effects analysis for the positive manipulation group was significant, F(2, 
40) = 8.14, p < 0.01, η² =  0.29. Post hoc analyses revealed that the positive manipulation 
group’s scores increased significantly from baseline (M = 4.57) to post (M = 5.71), with 
scores remaining significantly higher at follow-up (M = 5.57). However, scores did not 
significantly change from post to follow-up. Simple effects analysis for the negative 
manipulation group, F(2, 42) = 1.80, p = .18, η² = 0.08 and no information control group, 
F(2, 38) = 3.00, p = .06, η² = 0.14, were non-significant.  
No significant effects were found for time, F(2,120) = 1.54, p = .22, η² = 0.03, 
condition, F(2,60) = 0.06, p = .94, η² < .01, or group by time interaction, F(4,120) = 1.14, p 
= .34, η² = 0.04, for the statement, “please rate the extent to which you believe that your 
current level of physical activity benefits your physical wellbeing” (see Table 1).  
For the statement “Please rate how physically fit you believe you are,” no significant 
effects were found for time, F(2,120) = 0.53, p = .59, η² < 0.01, condition, F(2,60) = 0.02, p 
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= .98,) η² < 0.01, or group by time interaction, F(4,120) = 1.91, p = .11 η² = 0.06, (see Table 
1). 
Psychological Measures 
 Depression Anxiety Stress Scale. Separate mixed-model ANOVAs were performed on 
mean DASS subscale scores. Results of a 3 X 3 mixed model ANOVA indicated non-
significant main effects for time, F(2,116) = 3.02, p = .05, η² = 0.05, group, F(2, 58) = 1.11, 
p = .34, η² = 0.04, or group by time interaction, F(4, 116) = 1.79, p = .14, η² = 0.06 for the 
Depression subscale (see Table 2).    
Results of a 3 X 3 mixed model ANOVA for the Anxiety subscale indicated a 
significant main effect for time, F(2, 114) = 10.02, p < .01, η² = 0.15. Post hoc analyses 
indicated that the overall mean score of participants significantly decreased from baseline (M 
= 4.88) to post (M = 3.43) and from baseline to follow-up (M = 3.03). Scores were not 
significantly different from post to follow-up. The main effects of group, F(2, 57) = 0.65, p = 
.53, η² = 0.02, and group by time interaction, F(4, 114) = 1.23, p = .30, η² = 0.04 were not 
significant (see Table 2). 
Results of a 3 X 3 mixed model ANOVA for the Stress subscale indicated a 
significant main effect for time, F(2, 118) = 5.26, p < .01, η² = 0.08. Post hoc analyses 
indicated that the overall mean score of participants significantly decreased from baseline (M 
= 8.42) to post (M = 6.71) and from baseline to follow-up (M = 6.65). Scores were not 
significantly different from post to follow-up. The main effects of group, F(2, 59) = 1.70, p = 
.19, η² = 0.05, and group by time interaction, F(4, 118) = 0.67, p = .62, η² = 0.02, were not 
significant (see Table 2). 
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    Rosenberg Self-Esteem Scale. A 3 X 3 mixed-model ANOVA performed on mean 
RSES scores revealed no significant effect of time, F(2, 116) = 0.41, p = .66, η² = 0.01, 
group, F(2, 58) = 1.78, p = .18, η² = 0.06  or group by time interaction, F(4, 116) = 0.42, p = 
.80, η² = 0.01 (see Table 2).   
Four-Dimensional Mood Scale. Separate mixed-model ANOVAs were performed on 
the means of the two 4-DMS sub-scale scores. A 3 X 3 mixed-model ANOVA performed on 
mean UA-PD subscale scores indicated that the main effects for time, F(2, 120) = 2.02, p = 
.14, η² = 0.03, and group, F(2, 60) = 0.35, p = .71, η² = 0.01, were nonsignificant, and the 
group by time interaction also failed to reach significance, F(4, 120) = 1.77, p = .14, η² = 
0.06 (see Table 2). Similarly, analysis of mean PA-UD subscale scores revealed no 
significant main effect of time, F(2, 116) = 1.13, p = .32, η² = 0.02, or group (F(2, 58) = 
1.10, p = .34, η² = 0.04, or a group by time interaction, F(4, 116) = 0.30, p = .86, η² = 0.01 
(see Table 2). 
Anxiety Sensitivity Index. Results of a 3 X 3 mixed model ANOVA performed on 
mean ASI-3 scores indicated a significant main effect for time, F(2, 112) = 18.45, p < .01, η² 
= 0.25. Post hoc analyses indicated that the overall mean scores of participants significantly 
decreased from baseline (M = 13.68) to post (M = 10.25) and from baseline to follow-up (M 
= 9.37). Scores were not significantly different from post to follow-up. The main effect of 
group, F(2, 56) = 2.26, p = .11, η² = 0.08, and group by time interaction, F(4, 112) = 0.56, p 
= .70, η² = 0.02, were not significant (see Table 2). 
Physiological Measures 
 Separate mixed-model ANOVAs were performed on mean scores of each 
physiological variable. A 3 X 3 mixed model ANOVA analysis of weight revealed no 
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significant main effect of time, F(2, 114) = 0.91, p = .38, η² = 0.02, group, F(2, 57) = 1.87, p 
= .16, η² = 0.06, or a group by time interaction, F(4, 114) = 0.40, p = .81, η² = 0.01 (see 
Table 3).  Similarly, a 3 X 3 mixed model ANOVA revealed no significant main effect for 
time, F(2, 120) = 1.70, p = .19, η² = 0.03, or group, F(2, 60) = 0.87, p = .42, η² = 0.03, or a 
group by time interaction, F(4, 120) = 0.87, p = .48, η² = 0.03, for heart rate (see Table 3).  
Separate analyses were performed for diastolic and systolic blood pressure (see Table 
3). Results of a 3 X 3 mixed model ANOVA performed on diastolic blood pressure scores 
indicated a significant main effect for time, F(2, 120) = 4.49, p = .01, η² = 0.07. Post hoc 
analyses indicated that the participants’ diastolic blood pressure significantly decreased from 
baseline (M = 75.68) to post (M = 73.13) and remained decreased at follow-up (M = 73.46). 
Scores were not significantly different from post to follow-up. The main effect for group, 
F(2, 60) = 0.49, p = .62, η² = 0.02, and the group by time interaction (F(4, 120) = 0.26, p = 
.90, η² = 0.01) were not significant. 
Results of a 3 X 3 mixed model ANOVA performed on systolic blood pressure scores 
indicated a significant main effect for time, F(2, 120) = 5.48, p = .01, η² = 0.08 (see Table 3). 
Post hoc analyses indicated that the participants’ systolic blood pressure significantly 
decreased from baseline (M = 112.70) to post (M = 109.32) and remained lower at follow-up 
(M = 108.68). Scores did not significantly differ from post to follow-up. The main effect for 
group, F(2, 60) = 0.62, p = .54, η² = 0.02, and the group by time interaction, F(4, 120) = 
1.29, p = .28, η² = 0.04, were not significant.   
Discussion 
The purpose of the present study was to investigate the role of the placebo effect in 
the psychological and physiological benefits of exercise. Based on previous research, we 
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hypothesized that participants assigned to a positive expectancy manipulation group would 
show significant increases in perceived exercise participation and physical fitness with 
corresponding changes in physiological and psychological outcomes. Further, we 
hypothesized that participants assigned to the negative expectancy manipulation or no-
information control group would not demonstrate significant changes in perceived exercise 
participation, physical fitness, or physiological or psychological outcomes. A manipulation 
check revealed that participants in the positive expectancy group reported significant 
increases in perceived level of daily activity and benefits of current level of physical activity 
on psychological wellbeing. However, these changes in participant perceptions did not 
correspond with significant effects on any of the psychological or physiological outcome 
measures.   
Previous studies have reported significant group differences on psychological and 
physiological measures as a result of expectancy manipulations (Crum & Langer, 2007; 
Desharnais et al., 1993). Specifically, Desharnais et al. (1993) found a significantly greater 
increase on a measure of self-esteem among exercise participants who were provided with 
information regarding the psychological benefits of exercise compared to exercise 
participants who were not told of these benefits. However, the present research failed to 
replicate this finding, as the expectancy manipulation did not affect self-esteem scores. 
Furthermore, although some psychological and physiological variables changed over time, 
none of the outcome variables demonstrated an effect of group manipulation. Thus, the 
results of the present study generally suggest that changing individuals’ beliefs regarding 
their level of physical activity may not be sufficient to affect physiological and psychological 
variables. 
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Several potential reasons exist for the discrepancy between the present findings and 
those of previous research. For example, the frequency of the manipulation and duration of 
the study may have contributed to the lack of significant findings. Desharnais et al. (1993) 
reminded participants of the psychological benefits of exercise throughout the duration of a 
10-week exercise program and asked participants to be aware of both biological and 
psychological improvements. Similarly, participants in the month long study by Crum and 
Langer (2007) were provided with verbal information regarding the benefits of exercise and 
their current exercise levels, and written information was posted on a bulletin board in an 
area frequented by the room attendants. Thus, the placebo manipulation information was 
made available to participants in both studies on multiple occasions over the period of a 
month or more. In contrast, the current study provided feedback regarding the psychological 
benefits of exercise and the adequacy of the participants’ current level of physical activity on 
one occasion, and follow-up assessment sessions were conducted only one week later. Thus, 
it is possible that had the current study been longer in duration and included more frequent 
reminders about the benefits of exercise and participants’ exercise status, significant group 
differences may have emerged. 
The significant group by assessment time differences in perceived level of daily 
activity and benefits of current physical activity on psychological wellbeing suggest that a 
single positive manipulation succeeded in increasing perceived physical activity, as well as 
psychological benefits gained from physical activity.  However, the effects of the 
manipulation did not generalize to the specific variables assessed by the various measures.  
According to the expectancy model of placebo effects, a placebo functions by eliciting an 
expectation for a specific effect, which then generates that effect.  The significant group by 
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assessment time interaction effects in manipulation check items, with improvements by 
positive manipulation group participants, may reflect an expectation that overall 
psychological wellbeing should benefit from an increase in perceived daily activity in 
accordance experimenter suggestion. However, no specific suggestions were available for 
individual items on the various psychological measures, resulting in a lack of change on 
these measures. It is conceivable that a stronger manipulation, such as those utilized in the 
Crum and Langer (2007) and Desharnais et al. (1993) studies, would have allowed for greater 
generalization of perceived benefits to factors assessed by the various outcome measures.  
Interestingly, no changes in perceived benefits of daily physical activity on physical 
wellbeing or increased perceived physical fitness were endorsed.  This may be due to the 
characteristics of the study population, self-reported non-exercisers, who possessed well 
formed, static beliefs regarding their physical fitness and health.  It is commonly known that 
exercise affects physical wellbeing and fitness; it is not surprising then that the single 
manipulation was not successful in affecting these variables.  These results point to a failure 
of the manipulation to convince positive manipulation participants that their daily level of 
physical activity constitutes physical exercise and should provide them with the physical 
benefits of regular physical exercise.  Further, these findings suggest that perceived 
psychological benefits of physical activity may be more malleable than perceived physical 
benefits. 
The lack of change in perceived activity or psychological benefits gained from 
current physical activity from baseline to post or follow-up assessment among negative 
manipulation and control participants, suggests that feedback provided to the negative 
manipulation group merely reflected preconceived beliefs regarding their physical activity 
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and wellbeing.  Again, this is to be expected among a population of self-reported non-
exercisers, whose belief regarding their physical activity and fitness is likely to be poor.  
The current study possesses some methodological advantages to previous research.  
First, it employed a double-blind experimental design, ensuring that experimenter bias did 
not affect results. A double-blind design was not possible in either the Desharnais et al. 
(1993) or Crum and Langer (2007) studies. Second, participants were randomly assigned to 
experimental conditions to minimize the potential influence of error variability on study 
outcomes.  This was not the case in the Crum and Langer (2007) study, where participants 
were assigned to groups dependent on employment site. Third, the present study assessed the 
effects of exercise-related placebo expectancies on a variety of psychological and 
physiological outcomes, whereas previous research has focused on either psychological or 
physiological outcomes independently, and in the Desharnais et al. (1993) study, the only 
psychological outcome measure was self-esteem. Finally, this study is the first to include a 
negative expectancy group, in addition to positive expectancy and no expectancy groups, 
thus helping to clarify whether negative beliefs about the effects of exercise affect physical 
and psychological outcomes.  
As noted, previous research illustrated psychological and physical benefits of health 
related expectancy manipulations.  These results may have important implications for health 
care providers. The results of the current study suggest that expectancy manipulations can 
have an effect on perceived level of physical activity and perceived benefits gained from 
physical activity. However, these changes do not necessarily translate to significant changes 
on psychological and physiological variables. Additional research is needed to further clarify 
whether expectancy manipulations can generate or enhance the psychological and 
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physiological benefits associated with exercise, and if so, document the specific 
circumstances (e.g., duration, type) under which such manipulations exert an effect.  
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Appendix A 
Brief Screening Consent 
Dear Prospective Participant: 
We are conducting a study and looking for people with a variety of characteristics to 
participate in this study.  To find people with these characteristics, we are asking participants 
to complete a brief screening questionnaire.  If you are selected to participate in the study, we 
will contact you and provide you with further information about the study.  If you are not 
selected, all identifying information will be removed from these forms. All information you 
provide will be kept confidential. 
You may ask the researcher any questions related to this research project, or you may contact 
Simon Wullimann at (828)262-8641 or Dr. Joshua Broman-Fulks at (828)262-2726.  This 
project has been reviewed by the Institutional Review Board, which ensures that research 
projects involving human subjects follow federal regulations.  Any questions or concerns 
about your rights as a research participant should be directed to the Administrator for the 
IRB, Jay W. Cranston, M.D. at (828)262-2692 or Graduate Studies and Research, 
Appalachian State University, Boone, NC 28608. 
Your consent to participate in the screening portion of this study is implied if you elect to 
complete the screening questionnaire.            
Thank you for your participation. 
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Appendix B 
Demographic Information Questionnaire 
DEMOGRAPHIC QUESTIONNAIRE 
 First Name:________________  e-mail___________________     Phone #_____________ 
  
Age: _________   Gender: _____ Male _____ Female 
Academic Status:  ___ Freshman ___ Sophomore ___ Junior ___ Senior 
Major:_______________________________________________________________________________ 
Race/Ethnicity:    ___ White or Caucasian    ___ American-Indian or Alaskan Native 
  ___ Black or African-American  ___ Hispanic or Latino  
  ___ Asian    ___ Native Hawaiian or Other Pacific Islander 
  ___ Other (please specify) ____________________ 
 
Do you currently use any of the following substances: 
 Alcohol    Yes No If yes, how many drinks per week? _______ 
 Caffeine (soda, coffee, tea, etc.) Yes No If yes, how many caffeine drinks per 
day?______ 
 Cigarettes   Yes No If yes, how many cigarettes per day? _____ 
 Other Illicit Drugs  Yes No If yes, please specify _________________ 
       If yes, how often? ___________________ 
 
Are you currently involved in a regular exercise program?  Yes  No 
 If yes, how many times per week do you exercise on average? 
_______________________________ 
 If yes, how many minutes do you spend exercising each time you 
exercise?_____________________ 
 If yes, which type(s) of exercise do you participate in each week (check all that apply): 
   _____ Aerobic (walking, jogging, aerobics, stair stepping, cycling, swimming, etc.) 
_____ Resistance Training (weight lifting, nautilus, etc.) 
   _____ Sports (basketball, football, tennis, dance, etc.) 
_____ Yoga/Pilates 
_____ Other (please specify): _____________________________ 
 How many times have you exercised in the past 2 weeks?________________________________  
 
During your lifetime, have you ever had a panic attack?  Yes  No 
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 If yes, how many panic attacks have you had? (circle 1): 1-2 3-5 5-10 10-25 >25 
 
Have you ever been diagnosed with OR received treatment for any psychiatric or substance use 
problems? Yes        No 
 If yes, briefly specify the general nature of the problem, WHEN the problem occurred, and any 
treatment received:  
Diagnosis:______________________  When:_________________________ 
Treatment:__________________________  
 
Are you currently taking any psychiatric medications?  Yes  No 
 If yes, please specify the name(s) and or type(s) (anti-anxiety, antidepressant, etc) of medication 
you are taking: 
_______________________________________________________________________________
__________________ 
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Appendix C 
Institutional Review Board Approval 
 
To: Joshua Broman-Fulks  
Psychology ASU 
Boone, NC 28608 
 
From:___________________________________ 
          Jay Cranston, MD, Chair, Institutional Review Board  
 
Date: 9/15/2008 
 
RE: Notice of IRB Approval by Expedited Review (under 45 CFR 46.110)   
 
Study #: 09-0016 Study Title: Physical Activity in College Students 
Submission Type: Initial 
Expedited Category: (7) Research on Group Characteristics or Behavior, or Surveys, 
Interviews, etc. 
 
Approval Date: 9/15/2008  
Expiration Date of Approval: 9/14/2009 
 
This submission has been approved by the Institutional Review Board for the period 
indicated. It has been determined that the risk involved in this research is no more than 
minimal.  
 
 
Investigator’s Responsibilities:  
 
Federal regulations require that all research be reviewed at least annually. It is the Principal 
Investigator’s responsibility to submit for renewal and obtain approval before the expiration 
date. You may not continue any research activity beyond the expiration date without IRB 
approval. Failure to receive approval for continuation before the expiration date will result in 
automatic termination of the approval for this study on the expiration date.  
 
You are required to obtain IRB approval for any changes to any aspect of this study before 
they can be implemented. Should any adverse event or unanticipated problem involving risks 
to subjects or others occur it must be reported immediately to the IRB. 
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Appendix D 
Informed Consent Form 
Appalachian State University 
Consent Document for Research Participation 
 
Title of study: Physical Activity in College Students 
Investigators: Simon Wullimann and Joshua J. Broman-Fulks, Ph.D. 
 
Participant Name: ____________________________________  
 
I. Purpose of the study:   
The purpose of this study is to examine physical activity in college students. In this study, you will be 
asked to wear a pedometer and record your steps for two full days.  You will also be asked to complete a battery 
of psychological and physiological measure on three separate occasions.  
II. Procedures: 
Who can participate? 
 You must be 18 years old, in good physical health, and not currently taking psychiatric medication to 
participate in this study.  
 Description and Explanation of Procedures: 
 If you choose to take part in this study, you will be asked to complete a series of questionnaires, 
including a demographic questionnaire inquiring about your psychiatric history, illicit drug use, and substance 
use.  Additionally, you will be asked to wear a pedometer to record your steps for two full days.  You will be 
asked to complete the questionnaires a second time upon completion of the two days of recording your steps.  
You will then be asked to participate in a brief information session, and will be asked to return for a third 
appointment to complete the questionnaires a final time.  
When the study is complete and the results have been analyzed, the researcher will attempt to contact 
all participants of the study to invite them to come in for a debriefing session. In this session, participants will 
be informed of the findings of the study and given the opportunity to ask questions concerning these findings. 
At any time for any reason, you may decide to withdraw from the study without penalty. 
III. Risks and Discomforts: 
 You will be asked not to change your daily routine during the time of your participation in the study; 
therefore, you should not experience any additional risks or discomforts as a result of your participation in the 
study.    
IV. Benefits: 
 The information that you provide in this study may enable researchers to improve their understanding 
of typical daily activity, physiological functioning, and psychological functioning of college students in the 
United States. This will be discussed with you further after you complete the study. You will receive course 
credit for your participation in this study. Other research and non-research options for obtaining course credit 
are available. Please see your class instructor for more information.  
V. Extent of Anonymity and Confidentiality 
All information obtained during this study is confidential. That is, we protect the privacy of participants by 
withholding their names and other identifying information from all persons not connected with this study. 
The researcher will code all questionnaires and data by number and store them in a locked and secure area. 
Data that we may report in scientific journals or presentations will not include any information that 
identifies you as a participant in this study. Five years after the final publication of this study, all 
information and records will be destroyed. 
VI. Compensation: 
You will receive course credit for your participation in this study. You will receive 2 hours of research 
credit for completing this study. It is important that you complete the entire study, including the follow-up 
appointment, in order to receive credit for your participation. Credit slips will be handed out at the completion 
of the follow-up appointment.  You will not be penalized if you choose not to participate in or withdraw from 
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this study.  
VII. Freedom to Withdraw  
Participation in this research is completely voluntary. Therefore, at any time for any reason, you may 
choose to stop and withdraw from the study without penalty.  
Liability Statement: 
The University does not have a mechanism to provide medical care for physical or emotional injuries 
experienced from participation in this study. If you experience physical or emotional problems because of your 
participation, please notify a lab assistant or Dr. Broman-Fulks immediately. You will be provided with 
information about local treatment services, if desired. However, there are fees involved for services at these 
other sites, for which you will be responsible.    
Other Considerations: 
 If significant new information relating to this study becomes known which may relate to your 
willingness to continue to take part in this study, this information will be given to you by the investigator. 
VIII. Approval of Research 
This research project has been approved, as required, by the Institutional Review Board of Appalachian State 
University.  
       
IRB Approval Date    Approval Expiration Date  
 
X. Subject's Permission 
I have read and understand the Informed Consent and conditions of this project. I have had all my questions 
answered. I hereby acknowledge the above and give my voluntary consent:  
 
 
_________________________________________________Date__________  
Subject signature  
 
________________________________________________ Date __________  
Witness (Optional except for certain classes of subjects)  
 
Should I have any questions about this research or its conduct, I may contact:  
 
Simon Wullimann, (828) 989-2535, ss79668@appstate.edu 
Graduate Student, Clinical Health Psychology, Appalachian State University, Boone, NC 28608 
 
Joshua J. Broman-Fulks,PHD, (828) 262-2726, bromanfulksj@appstate.edu 
Assistant Professor, Psychology Department, Appalachian State University, Boone, NC 28608 
 
Jay W. Cranston, M.D., Chair, Instituational Review Board                 
Administrator, IRB, Graduate Studies and Research, Appalachian State University, Boone, NC 28608 
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 Appendix E 
Manipulation Checks 
MC 
Please rate your current level of daily physical activity on the following scale: 
 
Very Low  Low  Average  High  Very High 
1 2 3 4 5 6 7 8 9 
 
 
Please rate the extent to which you believe that your current level of physical activity benefits your psychological wellbeing: 
 
Very Little  A Little Somewhat Much  Very Much 
1 2 3 4 5 6 7 8 9 
 
 
 
Please rate the extent to which you believe that your current level of physical activity benefits your physical wellbeing: 
 
Very Little  A Little Somewhat Much  Very Much 
1 2 3 4 5 6 7 8 9 
 
 
Please rate how physically fit you believe you are: 
 
Not at all  
Physically fit 
 Somewhat 
Physically fit 
     Extremely      
Physically fit 
1 2 3 4 5 6 7 8 9 
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Table 1 
 
Manipulation Check Means and Standard Deviations by Intervention Condition at Baseline, Post and 
Follow-up 
 
  Positive 
Manipulation 
Negative 
Manipulation 
No Intervention 
Control 
 
Overall 
Session Measure Mean (SD) Mean (SD) Mean (SD) Means (SD) 
      
Baseline MC-1  4.19 (1.17) 4.55 (1.44) 4.55 (1.00) 4.43 (1.20) 
Post MC-1 4.90 (1.18) 4.36 (1.22) 4.65 (1.09) 4.64 (1.16) 
Follow-up MC-1 4.76 (1.04) 4.82 (0.96) 4.85 (1.09) 4.81 (1.03) 
Baseline MC-2 4.57 (1.86) 4.59 (1.44) 4.85 (1.63) 4.67 (1.64) 
Post MC-2 5.71 (1.55) 4.55 (1.68) 4.75 (1.41) 5.00 (1.55) 
Follow-up MC-2 5.57 (1.60) 5.05 (1.21) 5.50 (1.57) 5.37 (1.46) 
Baseline MC-3 4.62 (2.25) 5.14 (2.08) 5.50 (1.76) 5.09 (2.03) 
Post MC-3 5.38 (2.29) 4.73 (2.00) 4.95 (1.76) 5.02 (2.02) 
Follow-up MC-3 5.48 (1.63) 5.14 (1.32) 5.40 (2.11) 5.34 (1.69) 
Baseline MC-4 4.76 (1.49) 4.95 (1.29) 5.10 (1.48) 4.94 (1.42) 
Post MC-4 5.00 (1.38) 4.64 (1.68) 4.80 (1.15) 4.81 (1.40) 
Follow-up MC-4 4.76 (1.34) 4.86 (1.28) 4.75 (1.33) 4.79 (1.32) 
Note. MC = Manipulation Check   
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Table 2 
 
Psychological Measures Means and Standard Deviations by Intervention Condition at Baseline, Post and 
Follow-up 
 
  Positive 
Manipulation 
Negative 
Manipulation 
No Intervention 
Control 
 
Overall 
Session Measure Mean (SD) Mean (SD) Mean (SD) Means (SD) 
      
Baseline DASS-D 6.16 (6.35) 3.33 (3.44) 4.76 (5.33) 4.75 (5.04) 
Post DASS-D 3.73 (4.11) 3.57 (4.03) 4.57 (5.46) 3.96 (4.53) 
Follow-up DASS-D 4.58 (5.60) 1.81 (3.59) 4.24 (4.99) 3.54 (4.73) 
Baseline DASS-A 4.25 (4.72) 4.40 (3.52) 6.00 (3.99) 4.88 (4.08) 
Post DASS-A 2.45 (2.76) 3.90 (3.82) 3.95 (3.83) 3.43 (3.47) 
Follow-up DASS-A 3.05 (3.83) 2.75 (3.74) 3.30 (3.79) 3.03 (3.79) 
Baseline DASS-S 7.30 (6.77) 8.14 (5.97) 9.76 (6.57) 8.40 (6.44) 
Post DASS-S 5.05 (4.49) 6.10 (5.55) 8.90 (6.29) 6.68 (5.44) 
Follow-up DASS-S 6.10 (7.48) 5.33 (4.78) 8.48 (7.11) 6.64 (6.46) 
Baseline RSES 13.75 (1.89) 14.90 (2.66) 14.20 (2.12) 14.28 (2.22) 
Post RSES 13.90 (1.45) 14.90 (2.36) 14.55 (2.42) 14.45 (2.08) 
Follow-up RSES 14.20 (1.91) 15.19 (2.16) 14.15 (2.23) 14.51 (2.10) 
Baseline 4DMS-UA-PD 22.75 (4.50) 22.68 (3.92) 23.10 (5.05) 22.84 (4.49) 
Post 4DMS-UA-PD 22.55 (3.59) 21.64 (3.59) 21.14 (4.13) 21.78 (3.77) 
Follow-up 4DMS-UA-PD 21.65 (3.79) 21.05 (3.77) 23.43 (3.59) 22.04 (3.72) 
Baseline 4DMS-PA-UD 17.95 (4.49) 19.24 (3.67) 20.19 (4.46) 19.13 (4.21) 
Post 4DMS-PA-UD 18.68 (3.94) 18.57 (4.91) 19.67 (5.45) 18.97 (4.77) 
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Follow-up 4DMS-PA-UD 17.53 (4.71) 18.05 (3.71) 19.33 (4.86) 18.30 (4.43) 
Baseline ASI-3 12.67 (10.83) 10.95 (8.32) 17.14 (10.24) 13.59 (9.80) 
Post ASI-3 9.39 (8.81) 8.10 (6.76) 13.05 (9.58) 10.18 (8.38) 
Follow-up ASI-3 7.17 (9.59) 7.65 (7.85) 12.90 (11.98) 9.24 (9.81) 
Note. DASS-D = Depression Anxiety Stress Scale – Depression Subscale; DASS-A = 
Depression Anxiety Stress Scale – Anxiety Subscale; DASS-S = Depression Anxiety Stress 
Scale – Stress Subscale; RSES = Rosenberg Self-Esteem Scale; 4-DMS-UA-PD = Four-
Dimensional Mood Scale – Unpleasant Activation-Pleasant Deactivation Subscale, 4-DMS-
PA-UD = Four Dimensional Mood Scale – Pleasant Activation-Pleasant Deactivation; ASI-3 
= Anxiety Sensitivity Index–3 
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Table 3 
 
Physiological Measures Means and Standard Deviations by Intervention Condition at Baseline, Post and 
Follow-up 
 
  Positive 
Manipulation 
Negative 
Manipulation 
No Intervention 
Control 
Overall 
Session Measure Mean (SD) Mean (SD) Mean (SD) Mean  (SD) 
      
Baseline Weight 177.10 (61.32) 155.48 (38.97) 150.05 (38.42) 160.88 (46.24) 
Post Weight 178.80 (64.50) 155.40 (37.93) 150.68 (38.32) 161.63 (46.92) 
Follow-up Weight 178.25 (64.50) 155.25 (38.11) 150.45 (37.51) 161.32 (46.71) 
Baseline Heart Rate 79.81 (8.48) 80.09 (12.81) 86.75 (15.59) 82.22 (12.29) 
Post Heart Rate 79.24 (9.73) 79.91 (14.45) 80.70 (12.84) 79.95 (12.34) 
Follow-up Heart Rate 78.90 (10.35) 78.27 (12.97) 82.40 (16.04) 79.86 (13.12) 
Baseline BP-Diastolic 76.24 (8.32) 75.23 (9.32) 75.60 (8.33) 75.69 (8.66) 
Post BP-Diastolic 74.24 (8.04) 71.59 (6.46) 73.65 (6.94) 73.16 (7.15) 
Follow-up BP-Diastolic 73.95 (9.36) 72.23 (5.18) 74.30 (5.81) 73.49 (6.78) 
Baseline BP-Systolic 113.24 (11.89) 114.95 (14.80) 109.65 (11.53) 112.61 (12.74) 
Post BP-Systolic 111.29 (11.80) 108.05 (10.59) 108.65 (12.58) 109.33 (11.66) 
Follow-up BP-Systolic 108.95 (12.49) 110.73 (9.63) 106.15 (9.35) 108.61 (10.49) 
Note. Diastolic BP = Diastolic Blood Pressure; Systolic BP = Systolic Blood Pressure 
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